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Abstract
Herpes simplex virus type 1 (HSV-1) has the ability to enter many different hosts and cell
types by several strategies. This highly prevalent alphaherpesvirus can enter target cells
using different receptors and different pathways: fusion at a neutral pH, low-pH-dependent
and low-pH-independent endocytosis. Several cell receptors for viral entry have been
described, but several observations suggest that more receptors for HSV-1 might exist. In
this work, we propose a novel role for the proteolipid protein (PLP) in HSV-1 entry into the
human oligodendrocytic cell line HOG. Cells transfected with PLP-EGFP showed an
increase in susceptibility to HSV-1. Furthermore, the infection of HOG and HOG-PLP transfected cells with the R120vGF virus–unable to replicate in ICP4-defficient cells- showed an
increase in viral signal in HOG-PLP, suggesting a PLP involvement in viral entry. In addition, a mouse monoclonal antibody against PLP drastically inhibited HSV-1 entry into HOG
cells. PLP and virions colocalized in confocal immunofluorescence images, and in electron
microscopy images, which suggest that PLP acts at the site of entry into HOG cells. Taken
together these results suggest that PLP may be involved in HSV-1 entry in human oligodendrocytic cells.
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Introduction
Herpes simplex virus type 1 (HSV-1) is a highly prevalent human pathogen belonging to the
neurotropic alphaherpesviruses. HSV-1 infects epithelial cells and establishes latency in neurons in sensory ganglia [1, 2], but is also capable of spreading to the central nervous system
(CNS) and causing meningitis or encephalitis [3].
Heparan sulfate glycosaminoglycans act as attachment receptors for the viral glycoprotein
gC [4]. Although gC is not essential for viral entry, its absence decreases infectivity, due to a
reduced efficiency of viral binding to cells [5]. In the absence of gC, gB can mediate attachment
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to heparan sulfate [3]. Four viral glycoproteins, gB, gD, gH, and gL are necessary for viral entry
into cells [5, 6]. HSV gD binding to its receptors triggers the viral membrane fusion process
which requires the heterodimer gH/gL and the fusion protein gB. Fusion of the viral envelope
may occur with the plasma membrane in a pH-independent manner or with endosomal membrane after endocytosis [7, 8] to deliver the nucleocapsid and tegument into the cell cytoplasm.
The major entry receptors for gD include HVEM [9], nectin-1 [10] and 3-O-sulfated heparan
sulfate [11]. HVEM (herpesvirus entry mediator) is a member of the TNF receptor family
expressed in several tissues and cell types, including epithelial cells, fibroblasts, monocytes and
lymphocytes [9, 12, 13]. Nectins are molecules that mediate cell-cell adhesion in adherens junctions [14]. They are also expressed in a variety cell types, including epithelial cells, fibroblasts and
neurons [15, 16]. A third viral receptor, 3-O-sulfated heparan sulfate, which appears when certain D-glucosaminyl-3-O-sulfotransferases modify heparan sulfate, has been shown to be active
in CHO cells [11]. Other HSV-1 gB receptors, which have been found out recently, include
paired immunoglobulin-like type 2 receptor (PILR) alpha [17] and myelin-associated glycoprotein (MAG) [18]. It has been recently reported that the interaction of HSV gH/gL heterodimer
with its receptor αvβ6- or αvβ8-integrin results in the dissociation of gL from the heterodimer
and its release in the medium, a process that requires the presence of gD, nectin1, and gB [19].
The broad range of animal species infectable by HSV-1 suggests that surface receptors for
this virus are highly conserved or that different receptors might be used by HSV to enter different cell types [9, 20]. Indeed, data show that utilization of alternative receptors by HSV-1 is
quite significant, since it can use different receptors according to the target cell [12]. Moreover,
HSV-1 can also enter different cell types not only using different receptor, but also by different
pathways: in many cultured cell lines, such as Vero and HEp-2, HSV-1 enters cells by a pHneutral fusion with the cell surface, but entry into HeLa and CHO-K1 cells does depend on
endocytosis and subsequent exposure to a low pH [8].
Oligodendrocytes (OLs) are the glial cells that produce myelin,–the electrically insulating
layer that surrounds axons [21, 22]–in the CNS [23]. Proteolipid protein (PLP), together with
DM20, a smaller isoform generated by alternative splicing, are the most abundant proteins in
the CNS myelin, comprising around the 50% of total myelin proteins [24]. PLP has a crucial
structural role in maintaining the stability of the intraperiod lines of compact myelin [25, 26]
although other nonstructural roles for this protein have been also proposed [27, 28].
Previous work carried out by our laboratory has shown that both nectin-1 and HVEM are
functioning as HSV-1 receptors in HOG cells and that the virus can follow an endocytic pathway to infect these cells. Moreover, we have also reported an increase in PLP levels in cells
infected with K26GFP [29]. In the present work, we propose that PLP plays a role in HSV-1
entry into the human HOG oligodendrocytic cell line. Several pieces of evidence support this
novel role for PLP. First, cells transfected with PLP-EGFP showed an increase in susceptibility
to HSV-1. Second, antibodies directed to PLP significantly blocked viral entry. Third, the
increased infection of HOG-PLP cells compared to HOG cells by a replication-deficient ICP4negative virus (R120vGF) confirms that PLP plays a role early in infection. Finally, PLP
colocalized with virions in electron microscopy images and by immunofluorescence (when
HSV glycoprotein gD is stained). Taken together these results suggest that PLP could participate in a new way of viral entry in oligodendrocityc cells.

Materials and Methods
Antibodies, reagents and plasmids
Horseradish peroxidase-conjugated secondary anti-IgG antibodies were from Millipore (Billerica, MA, USA). Anti-GFP rabbit polyclonal serum A6455, Alexa 488-, Alexa 647- and Alexa
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594-conjugated secondary antibodies were obtained from Molecular Probes (Eugene, OR,
USA). Low-glucose DMEM, fetal bovine serum (FBS), o-nitrophenyl-β-D-galactopyranoside
(ONPG), carboxymethylcellulose sodium salt (CMC) medium-viscosity and protease inhibitor
cocktail were purchased from Sigma Chemical Co. (St. Louis, MO, USA). Mowiol was from
Calbiochem (Merck Chemicals, Germany). Jet-PEI was from Polyplus-transfection (Illkirch,
France).
PLP-EGFP was generated by fusing EGFP to the COOH terminus of PLP by gene fusion
PCR. The fusion product was cloned into pEGFPN1 vector using the EcoRI–NotI site. Stable
cell lines were obtained by the cotransfection of PLP-EGFPNI and pMSCV-hygro (CLONTECH Laboratories, Inc.) followed by the selection of clones by incubation with hygromycin.

Cell lines and virus
The human HOG cell line, established from a surgically removed human oligodendroglioma
[30] was kindly provided by Dr. A. T. Campagnoni (University of California, UCLA, USA).
Cells were cultured on Petri dishes in GM containing low-glucose DMEM supplemented with
10% heat-inactivated fetal bovine serum (FBS), penicillin (50 U/mL) and streptomycin (50 μg/
mL) at 37°C in an atmosphere of 5% CO2. Differentiation medium (DM) consisted of serumfree low-glucose DMEM supplemented with additives [31].
To produce a PLP-EGFP stably-expressing cell line HOG cells were stably transfected with
PLP-EGFP plasmid. Twenty-four hours prior transfection of the HOG cell line, 106 cells were
plated in 100 mm Petri dishes with GM. Cells were transfected with 8 μg of DNA, using the JetPEI reagent according to the manufacturer’s instructions. Cells were incubated with DNA for
24 h in GM and, 48 h after transfection, selection of stable HOG cell transfectants was initiated
by treatment with 1 mg/ml G418 sulfate.
R120vGF is an EGFP-expressing recombinant virus containing vhs gene and inmediate
early genes except ICP4 [29]. This virus was propagated in E5 cells, a Vero cell line expressing
the ICP4 protein of HSV-1 [32]. After entry into cells, R120vGF virus expresses EGFP and
immediate early proteins, but it is not able to complete the viral cycle due to the abscence of
ICP4. K26GFP virus was a kind gift of Dr. Desai (Johns Hopkins University, Baltimore, USA).
It was obtained by fusing GFP to the HSV-1 capsid protein VP26 [33]. K26GFP and wild type
HSV-1 (F strain) viruses were propagated and titrated on Vero cells. CHO-K1 cells were a kind
gift of Dr. R. Longnecker (Northwestern University, Chicago, USA).

Viral infections
For viral infection assays, 2x106 HOG cells growing in 25 cm2 flasks were mock infected or
infected with the corresponding virus. During viral adsorption, cells were maintained in
DMEM with antibiotics in the absence of FCS. Subsequently, cultures were rinsed and cultured
in its corresponding medium. Viral titer was quantified by an endpoint dilution assay determining the 50% tissue culture infective dose (TCID50) in Vero cells, considering the final dilution that shows cytopathic effect and using the Reed and Muench method.
For plaque assay, confluent monolayers of cells plated in 6-well tissue culture dishes were
infected with serial dilutions of HSV-1. After viral adsorption, cells were washed and overlayed
with CMC. The CMC solution was prepared in distilled water at 2% (w/v) and stirred at room
temperature for one hour. CMC overlay (1% final concentration) was prepared by mixing
equal volumes of CMC 2% and medium double-strength. Two millilitres of CMC overlay were
added to each well. Plates were incubated at 37°C in a humidified 5% CO2 incubator for 48
hours. After that, CMC overlay was aspirated and cells were washed with PBS. Plaques were
visualized by staining with crystal violet.
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Viral entry assay
To determine HSV-1 entry, confluent monolayers of HOG cells plated in 96-well tissue culture
dishes were infected with a recombinant HSV-1 (KOS) gL86, which expresses β-galactosidase
upon entry into cells. After 6 h p.i., β-galactosidase assays were performed using a soluble substrate ONPG assay. The enzymatic activity was measured at 410 nm using a Benchmark microplate reader (Bio Rad). HSV-1 resistant CHO-K1 cells were used as control.

Antibody blocking assay
HOG cells cultured in DM and plated in 24-well plates were preincubated at room temperature
with twofold dilutions of a mouse monoclonal anti-PLP antibody for 90 min. Cells were then
challenged with identical doses of K26GFP at 5 × 105 pfu per well at 37°C. After 20 hours, the
cells were washed twice with PBS and treated for flow cytometry. Mouse serum was used as a
control.

Immunoblot analysis
Samples were subjected to SDS-PAGE in 10% acrylamide gels under reducing conditions and
transferred to Immobilon-P membranes (Millipore). After blocking with 5% nonfat dry milk,
0.05% Tween 20 in PBS, blots were incubated for 1 h at room temperature with primary antibodies. After several washes with 0.05% Tween 20 in PBS, blots were incubated for 1 h with secondary antibodies coupled to horseradish peroxidase, washed extensively, and developed using
an enhanced chemiluminescence Western blotting kit (ECL, Amersham, UK).

Flow Cytometry Analysis
To perform FACS analysis, cells were dissociated by incubation for 1 minute in 0.05% trypsin/
0.1% EDTA (Invitrogen) at room temperature and washed and fixed in 4% paraformaldehyde
for 15 minutes. Then, cells were rinsed and resuspended in PBS. Cells were analyzed using a
FACSCalibur Flow Cytometer (BD Biosciences).

Immunofluorescence microscopy
Cells cultured on DM and grown on glass coverslips were fixed in 4% paraformaldehyde for
20 min and rinsed with PBS. Cells were then permeabilized with 0.2% Triton X-100, rinsed and
incubated for 30 min with 3% bovine serum albumin in PBS with 10% human serum, to block
the HSV-1-induced IgG Fc receptors. For double and triple-labeled immunofluorescence analysis, cells were incubated for 1 h at room temperature with the appropriate primary antibodies,
rinsed several times and incubated at room temperature for 30 min with the relevant fluorescent secondary antibodies. Antibodies were incubated in the presence of 10% human serum.
Controls to assess labeling specificity included incubations with control primary antibodies or
omission of the primary antibodies. After thorough washing, coverslips were mounted in
Mowiol. Images were obtained using an LSM510 META system (Carl Zeiss) coupled to an
inverted Axiovert 200 microscope. Processing of confocal images was made by FIJI-ImageJ
software.

Immunogold-labelling EM
HOG-PLP cells were mock-infected or infected with HSV-1 at a m.o.i. of 100 and incubated
for 1 h at 4°C. Then cells were washed with PBS and fixed in 4% paraformaldehyde in 0.1 M
sodium phosphate buffer, pH 7.4, at 4°C for 2 hour. After that, cells were incubated overnight
with 8% paraformaldehyde in 0.1 M sodium phosphate buffer, pH 7.4, at 4°C. Fixed cells were
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washed in PBS containing 20 mM glycine and embedded in 12% gelatine, infiltrated with 2.3
M sucrose and frozen in liquid nitrogen. Cryosections were stained with a mouse monoclonal
anti-PLP antibody. Primary antibody was detected with 15 nm anti-mouse-gold (British BioCell, Cardiff, UK). Cryosections were examined with a JEM1010 transmission EM (Jeol,
Tokyo, Japan).

Results
PLP overexpression increases HSV-1 infection in HOG cells
The role of PLP in the infection of the human oligodendrocytic HOG cells was tackled in this
study. First of all, to assess whether overexpression of PLP was correlated with an increase in
HSV-1 infection, we produced a PLP-EGFP-expressing HOG cell line named HOG-PLP (Fig
1). To address the role of PLP in HSV plaque formation, confluent monolayers of HOG cells
were infected with serial dilutions of HSV-1 as previously described [29]. A significantly
(p<0.01) larger number of plaques was counted in HOG-PLP (a 2,7 times increment) compared to HOG cells when cells were infected with the same viral dose (Fig 2A). Furthermore,
the average plaque size of infected HOG-PLP cells was slightly larger than that of plaques in
HOG cells, suggesting that PLP could also be affecting viral spread. Additionally, HOG and
HOG-PLP cells were infected at a m.o.i of 1 with HSV-1 and the viral progeny was titrated by

Fig 1. Expression of PLP-EGFP in HOG cells. Cells stably transfected (A) or mock-transfected (B) with PLP-EGFP were fixed and processed for confocal
indirect immunofluorescence analysis with a polyclonal anti-PLP antibody. As the images show, the localization pattern of exogenous PLP (green) is similar
to that of endogenous PLP (red). (DIC: Differential Interference Contrast).
doi:10.1371/journal.pone.0147885.g001
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Fig 2. Effect of PLP overexpression on HSV-1 infection. HOG and HOG-PLP cells were infected with
HSV-1. PLP-transfected HOG cells showed higher susceptibility to HSV-1 than mock-transfected cells (A and
B). A. Plaque assay showed an increase in the number of plaque forming units (p.f.u.) per ml in PLPtransfected cells compared to mock-transfected control cells. Two representative wells are also shown. The
average plaque size of infected HOG-PLP cells is slightly larger than that of plaques in HOG cells. B. Cells
were infected at a m.o.i. of 0.1 with HSV-1, and viral titers were determined 20 h p.i. by TCID50. Virus yield
was significantly increased in PLP-transfected cells. The increment on viral yield correlated with the presence
of PLP-EGFP, as shown by immunoblotting (C) with an anti-GFP antibody. C. HOG and HOG-PLP cells were
infected with HSV-1 at an m.o.i. of 0,1. After 24 h p.i., equal number of cells were subjected to SDS–PAGE
and analyzed by immunoblotting with a rabbit polyclonal anti-GFP antibody.
doi:10.1371/journal.pone.0147885.g002

determining the TCID50/ml. Viral yield of infected HOG-PLP cells was significantly (p<0.01)
higher compared to that of HOG non-transfected cells (Fig 2B). PLP-EGFP overexpression led
to a 6 fold increase in viral yield. This increase in viral progeny production correlated with the
presence of PLP-EGFP (Fig 2C). In addition, Fig 2C shows an increase in PLP-EGFP in HSV-1
infected cells, which coincides with our previous results. GFP-MAL2/HOG cell line overexpressing exogenous MAL2 protein [34], used as negative control, showed no significant
increase in susceptibility to HSV-1 (data not shown).
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Role of PLP in HSV-1 infection
In order to investigate whether the above showed increase in viral yield was due to an increase
in the viral entry, we performed an entry assay by infecting HOG and HOG-PLP cells with the
recombinant R120vGF virus [29], which is unable to replicate in ICP4-defficient cells. Using
the R120vGF virus, we were able to assess viral entry by detection of immediate early proteins
except ICP4. HOG and HOG-PLP cells were infected with R120vGF at a m.o.i. of 1. After 24 h
p.i., an equal number of cells were subjected to SDS–PAGE and analyzed by immunoblotting
with anti-HSV-1 antibody to detect immediate early proteins ICP0, ICP22, ICP27 and ICP47.
In HOG-PLP cells, a significant (p<0.01) 3 fold increase in viral signal was observed, suggesting a plausible PLP involvement in virus entry (Fig 3A). Subsequently, we performed an entry
assay using the recombinant HSV-1 (KOS) gL86, which expresses β-galactosidase upon entry
into cells. Confluent monolayers of HOG cells plated in 96-well tissue culture dishes were
infected with HSV-1 (KOS) gL86 at a m.o.i. of 10. After 6 h p.i., we analyzed the β-galactosidase
activity at 410 nm in a microplate reader, including HSV-1 resistant CHO-K1 cells as negative
control. Again, results showed a significant (p<0.01) increase (1.5 times) in viral entry in
HOG-PLP cells compared with HOG cells (Fig 3B).
Next, we carried out an antibody blocking assay. HOG cells plated in 24-well plates were
preincubated at room temperature with twofold dilutions of a mouse monoclonal anti-PLP
antibody for 90 min. Cells were then challenged with identical doses of the recombinant
K26GFP virus–obtained by fusing GFP to the HSV-1 VP26 capsid protein- at 5 × 105 pfu per
well at 37°C. After 20 hours, the cells were rinsed twice with PBS and treated for flow cytometry. Pretreatment with the anti-PLP monoclonal antibody markedly reduced infection (7
times) of HOG cells by HSV K26GFP (Fig 3C). In contrast pretreatment with polyclonal serum
antibodies only had a limited effect on infection. In addition, a goat polyclonal serum against
PLP was also able to reduce infection of HOG cells (data not shown).

Interaction of PLP and HSV-1
Once considered the possibility that PLP is involved in viral entry, we decided to evaluate the
association between PLP and a HSV-1. To uncover such a possible relationship, we first performed an immunofluorescence assay. To that aim, we infected HOG cells with HSV-1 at a m.
o.i. of 100 and subsequently incubated for 1 h at 4°C. Then, HOG-PLP cells were fixed and
stained with anti-gD antibody LP2 for confocal immunofluorescence analysis. Analysis of confocal images showed partial colocalization of HSV-1 virions and PLP at patches of the cell
membrane (Fig 4).
The colocalization between PLP and virions was confirmed by electron microscopy.
HOG-PLP cells were mock-infected or infected with HSV-1 at a m.o.i. of 100 and incubated
for 1 h at 4°C. Then, cells were fixed, PLP was stained with colloidal gold-labelled antibody and
cells were processed for observation as described in materials and methods. Fig 5 shows representative images of virions attached to HOG-PLP cells. The colloidal gold particles localize
PLP and showed an accumulation of PLP at the site of HSV binding to the plasma membrane
(Fig 5). These visual observations are consistent with our functional data in supporting a role
for PLP in entry of HSV into HOG cells.

Discussion
HSV-1 has acquired the ability to enter many different hosts and cell types by using several
strategies. The most relevant factors that have allowed this ability to infect such a wide range of
hosts and tissues include the number of glycoproteins involved in viral entry, the existence of
multiple alternative cell receptors and the varied strategies of viral entry [35]. The two major
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Fig 3. Viral entry assays. A. HOG and HOG-PLP cells were infected with R120vGF at a m.o.i. of 1. After 24
h p.i., equal number of cells were subjected to SDS–PAGE and analyzed by immunoblotting with a rabbit
polyclonal anti-HSV-1 antibody to detect immediate early proteins. In HOG-PLP cells, an increase in viral
signal was observed. A positive control of HOG cells infected with HSV-1 was also included. The histogram
corresponds to the quantification of the immunoblot signals expressed in arbitrary scanning units. B.
Confluent monolayers of cells plated in 96-well tissue culture dishes were infected with a recombinant HSV-1
(KOS) gL86 at a m.o.i. of 10. After 6 h p.i., the β-galactosidase activity at 410 nm was analyzed in a
microplate reader. Optical density (OD) was increased in HOG-PLP cells compared to HOG cells. C. To
perform an antibody blocking assay, HOG cells blocked with an anti-PLP antibody were infected at a m.o.i. of
1 with K26GFP and processed for flow cytometry, analyzing fluorescence of GFP. Percentage (%) of max
designates the number of cells relative to the maximum fraction. For each fluorescence intensity within
positive cells, the percentage of cells incubated with blocking mouse anti-PLP antibody is considerably lower
than control cells incubated without blocking antibodies (red plot) or cells incubated with a control mouse
serum (yellow plot). Data are representative of 3 independent experiments.
doi:10.1371/journal.pone.0147885.g003

entry pathways are fusion at a neutral pH and low-pH-dependent endocytosis [5, 35]. A third
pathway, low-pH-independent gD-dependent endocytosis, has also been described [36]. In
addition to the initially established cell receptors, others, such as PILRα [17], MAG [18] and
non-muscle myosin heavy chain-IIA [37], have been described, and several signs suggest that
more receptors for HSV-1 must exist, for instance, a gB receptor associated to lipid-rafts or
gH-gL receptors.
Previous work carried out by our group [29] indicated that HSV-1 entry in oligodendrocytic
HOG cells could be mediated by several possible receptors and/or by endocytic pathway and,
therefore, we decided to investigate other feasible mediators of entry in our oligodendrocytic

PLOS ONE | DOI:10.1371/journal.pone.0147885 January 25, 2016

8 / 13

Role of PLP in HSV-1 Oligodendrocytic Infection

Fig 4. Colocalization between PLP and HSV-1. HOG cells incubated at 4°C for 1 h at a m.o.i. of 100 with HSV-1 were fixed and processed for confocal
double-label indirect immunofluorescence analysis with an anti-gD LP2 antibody. Images correspond to confocal slices of 0.6 μm. Images show partial
colocalization (yellow) between PLP-EGFP (green) and virions (red). (DIC: Differential Interference Contrast).
doi:10.1371/journal.pone.0147885.g004
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Fig 5. EM immunocolocalization of PLP-EGFP and HSV-1. HOG-PLP cells were mock-infected or infected
with HSV-1 at a m.o.i. of 100 and incubated for 1 h at 4°C. Then, cells were fixed and processed for
observation by electron microscopy. Panels A, B and C show the presence of virions (arrows) attached to the
plasma membrane localized next to colloidal gold particles (arrowheads) corresponding to PLP.
doi:10.1371/journal.pone.0147885.g005

model. MAG, a myelin protein, has been proved to mediate HSV-1 entry in promyelocytes
through gB interaction [18]. Nevertheless, the undetectable level of MAG expression observed
in HOG cells prompted us to look for another candidate that might be implicated in HSV-1
entry. Therefore, we decided to ascertain whether PLP, the major myelin protein, could be
involved in viral entry into HOG cells. As a first step, and to investigate whether overexpression
of PLP was correlated with an increase in HSV-1 infection, we produced a PLP-EGFP expressing HOG cell line named HOG-PLP. Plaque assay of HOG-PLP cells infected with HSV-1
showed an increment in the number of plaques compared to HOG when cells were infected
with the same viral dose. In addition, the TCID50/ml showed that viral yield of infected
HOG-PLP cells was significantly higher compared to that of HOG non-transfected cells, an
enhancement that paralleled the presence of PLP-EGFP.
To determine whether that increase in viral yield was due to an increase in the viral entry,
we used R120vGF virus [29]. When the infection of HOG and HOG-PLP cells with R120vGF
virus took place, we found an increase in viral signal in HOG-PLP cells, suggesting that PLP
was involved in entry rather than a later step in viral replication. In addition, the fact that a
mouse monoclonal antibody against PLP drastically inhibited HSV-1 entry in HOG cells suggests a direct role in the entry process. These functional data are supported by the fact that PLP
and virions colocalized in confocal immunofluorescence and electron microscopy images,
which showed virions attached to the plasma membrane next to PLP (visualized by colloidal
gold particles). Taken together these results strongly support an involvement of PLP in the process of HSV-1 entry in oligodendrocytic cells.
The exact mechanism by which PLP enhanced HSV entry remains unclear. We observed
that overexpression of PLP-GFP in the gD-receptor negative B78H1 cells did not allow entry
like nectin-1 and HVEM did (data not shown) [38, 39]. This indicates that PLP does not substitute for a gD receptor such as nectin-1 or HVEM in those cells and it is unlikely that PLP acts
by binding gD like the other known receptors. Nevertheless, a PLP effect on the viral attachment or the fusion process cannot be excluded. However, since we showed that nectin-1 and
HVEM were functional on oligodendrocytes [29], it is possible that PLP modulates the activity
of these receptors. The reported gB receptors (PILRalpha, MAG and NMHCIIA) also enhance
HSV in the presence of a gD receptor. Therefore it is also possible to envisage a similar function
for PLP in HSV entry into HOG cells. On the other hand, PLP might be also involved in the
viral entry from the cell surface by endocytosis. Future studies will define whether PLP act similarly to those surface proteins during infection of oligodendrocytes.
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